An increase in first time applications for unemployment benefits weighed the markets down to a lower open with the Dow falling 55 points to 16,229. Nasdaq dropped 23 points to 4,596.
On the upside
Sarepta Therapeutics (Nasdaq: SRPT) reported additional positive data from a Phase IIb study of its Duchenne muscular dystrophy drug eteplirsen.
Pacific Biosciences of California (Nasdaq: PACB) launched a new nucleic acid sequencing platform.
PBF Energy (NYSE: PBF) will acquire Exxon Mobil's (NYSE: XOM) in Torrance for approximately $537.5 million.
On the downside
Dunkin' Brands Group (Nasdaq: DNKN) forecast third revenue below analyst expectations and announced plans to close 100 stores.
Crocs (Nasdaq: CROX) cut its third quarter sales guidance.
Illumina (Nasdaq: ILMN) launched the BaseSpace Professional and Enterprise Editions of its Laboratory Information Management Systems solutions but the stock price fell.
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE while decliners edged out advancers by nearly 10 to 9 on Nasdaq. The broader S&P 500 slipped 3 points to 1,916. Bitcoin held steady at $235.
Lower open as jobless claims rise
October 01, 2015 at 10:43 AM EDT